We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.4B
AUM Growth
+$2.35B
Cap. Flow
-$652M
Cap. Flow %
-1.96%
Top 10 Hldgs %
25.9%
Holding
1,133
New
72
Increased
394
Reduced
425
Closed
76

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$242M
2
AMZN icon
Amazon
AMZN
+$69.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$67M
4
UBS icon
UBS Group
UBS
+$59.2M
5
LW icon
Lamb Weston
LW
+$58.5M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$105M
2
AAPL icon
Apple
AAPL
+$87.1M
3
APTV icon
Aptiv
APTV
+$80.3M
4
TSCO icon
Tractor Supply
TSCO
+$80M
5
DE icon
Deere & Co
DE
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 35.56%
2 Healthcare 16.52%
3 Consumer Discretionary 11.68%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
301
Molson Coors Class B
TAP
$7.32B
$18M 0.05%
267,847
+2,557
+1% +$162K
TROW icon
302
T. Rowe Price
TROW
$22.2B
$18M 0.05%
147,641
+22,915
+18% +$2.56M
SPY icon
303
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$17.9M 0.05%
34,266
COO icon
304
Cooper Companies
COO
$10.1B
$17.9M 0.05%
176,279
-13,481
-7% -$1.3M
GLW icon
305
Corning
GLW
$124B
$17.9M 0.05%
542,181
+532,143
+5,301% +$16.9M
RHI icon
306
Robert Half
RHI
$3.92B
$17.7M 0.05%
223,403
+35,056
+19% +$2.82M
HEI icon
307
HEICO Corp
HEI
$41.5B
$17.5M 0.05%
91,837
+3,599
+4% +$668K
MOH icon
308
Molina Healthcare
MOH
$10.8B
$17.5M 0.05%
42,622
-3,485
-8% -$1.35M
CB icon
309
Chubb
CB
$132B
$17.4M 0.05%
67,334
+3,978
+6% +$978K
SYM icon
310
Symbotic
SYM
$5.55B
$17.4M 0.05%
+387,490
New +$17M
IQV icon
311
IQVIA
IQV
$44.4B
$17.4M 0.05%
68,843
+26,017
+61% +$6.07M
CP icon
312
Canadian Pacific Kansas City
CP
$78.3B
$17.2M 0.05%
195,158
+34,945
+22% +$2.93M
AGCO icon
313
AGCO
AGCO
$8.67B
$17.1M 0.05%
139,151
-46,397
-25% -$5.4M
SYF icon
314
Synchrony
SYF
$24.7B
$17.1M 0.05%
395,452
-247,406
-38% -$9.85M
OTIS icon
315
Otis Worldwide
OTIS
$26.1B
$16.7M 0.05%
168,528
+6,085
+4% +$562K
BLD
316
DELISTED
TopBuild
BLD
$16.5M 0.05%
37,475
+6,818
+22% +$2.67M
ESTC icon
317
Elastic
ESTC
$8.94B
$16.5M 0.05%
+164,637
New +$19M
WAT icon
318
Waters Corp
WAT
$41B
$16.4M 0.05%
47,744
-12,348
-21% -$4.06M
CNC icon
319
Centene
CNC
$33.4B
$16.3M 0.05%
207,422
+28,189
+16% +$2.18M
ALNY icon
320
Alnylam Pharmaceuticals
ALNY
$31.9B
$16.1M 0.05%
107,636
-59,417
-36% -$9.91M
BNTX icon
321
BioNTech
BNTX
$24.3B
$15.6M 0.05%
168,986
-9,886
-6% -$948K
RARE icon
322
Ultragenyx Pharmaceutical
RARE
$1.29B
$15.5M 0.05%
332,767
+55
+0% +$2.59K
APA icon
323
APA Corp
APA
$16.6B
$15.4M 0.05%
448,240
+249,535
+126% +$7.91M
KIM icon
324
Kimco Realty
KIM
$15.4B
$15.4M 0.05%
783,250
+102,443
+15% +$2.04M
COLD icon
325
Americold
COLD
$4.28B
$15.2M 0.05%
611,820
+14,826
+2% +$405K

Similar funds

Axa's Q1 2024 Portfolio in Review

As of Q1 2024, Axa held 1,133 positions worth $33.4B, up 7.6% from $31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Axa's Q1 2024 filing shows 72 new, 394 increased, 425 reduced and 76 closed positions. Its largest new stake was Lamb Weston: 561,708 shares worth $59.8M. The largest sale was Axonics, Inc. Common Stock, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2024 buy was Lamb Weston: 561,708 shares worth $59.8M.
  • Axa added most to Meta Platforms (Facebook) in Q1 2024, an estimated $242M increase.
  • Axa's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $105M.
  • Axa fully exited Archer Daniels Midland in Q1 2024, selling an estimated $53.4M.
  • Axa's ten largest holdings make up 26% of its $33.4B portfolio in Q1 2024.
  • Axa opened 72 new positions and closed 76 in Q1 2024.
  • Axa's portfolio value rose 7.6% quarter-over-quarter to $33.4B.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.